EAGLE HARBOR ASSET MANAGEMENT INC /ADV’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$299K Sell
1,905
-97
-5% -$14.5K 0.23% 110
2026
Q1
$306K Sell
2,002
-155
-7% -$23.8K 0.26% 108
2025
Q4
$297K Hold
2,157
0.25% 113
2025
Q3
$277K Buy
2,157
+200
+10% +$24.4K 0.24% 115
2025
Q2
$237K Buy
+1,957
New +$221K 0.23% 116
2023
Q2
Sell
-2,262
Closed -$208K 118
2023
Q1
$208K Hold
2,262
0.28% 105
2022
Q4
$205K Buy
+2,262
New +$191K 0.3% 101
2022
Q3
Sell
-2,519
Closed -$213K 105
2022
Q2
$213K Hold
2,519
0.33% 94
2022
Q1
$221K Buy
+2,519
New +$218K 0.29% 108

Other funds holding NVS

EAGLE HARBOR ASSET MANAGEMENT INC /ADV's NVS Position: Q2 2026 in Review

EAGLE HARBOR ASSET MANAGEMENT INC /ADV reduced its Novartis (NVS) stake by 4.8% in Q2 2026, selling an estimated $14.5K and leaving 1,905 shares worth $299K. The position accounts for 0.23% of the portfolio, ranked #110.

EAGLE HARBOR ASSET MANAGEMENT INC /ADV first reported a position in NVS in Q1 2022 and has held it in 9 quarters since. The position peaked at $306K in Q1 2026. 1,179 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • EAGLE HARBOR ASSET MANAGEMENT INC /ADV held 1,905 shares of Novartis worth $299K as of Q2 2026.
  • EAGLE HARBOR ASSET MANAGEMENT INC /ADV sold 97 Novartis shares in Q2 2026, an estimated $14.5K.
  • Novartis made up 0.23% of EAGLE HARBOR ASSET MANAGEMENT INC /ADV's portfolio in Q2 2026, its #110 holding.
  • EAGLE HARBOR ASSET MANAGEMENT INC /ADV first reported a position in Novartis in Q1 2022 and has held it in 9 quarters since.
  • EAGLE HARBOR ASSET MANAGEMENT INC /ADV's Novartis position peaked at $306K in Q1 2026.
  • 1,179 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on EAGLE HARBOR ASSET MANAGEMENT INC /ADV's 13F filing for Q2 2026, filed 11 Aug 2026.